• 1. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 2. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 5. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932

Methyl 2-(2-bromo-3-chlorophenyl)acetate: An Overview of a Versatile Intermediate in Pharmaceutical Synthesis

Methyl 2-(2-bromo-3-chlorophenyl)acetate (CAS No. 1021089-12-2) is a valuable intermediate in the pharmaceutical and chemical industries, particularly in the synthesis of various bioactive compounds and drug candidates. This compound, characterized by its unique bromo and chloro substituents, offers a versatile platform for further chemical modifications, making it an essential building block in the development of novel therapeutic agents.

The chemical structure of Methyl 2-(2-bromo-3-chlorophenyl)acetate consists of a methyl ester group attached to an acetate moiety, which is itself substituted with a 2-bromo-3-chlorophenyl group. This combination of functional groups provides a rich array of reactive sites that can be exploited in various synthetic pathways. The bromine and chlorine atoms, in particular, serve as excellent leaving groups for subsequent nucleophilic substitution reactions, enabling the introduction of a wide range of functional groups.

Recent advancements in synthetic chemistry have highlighted the importance of Methyl 2-(2-bromo-3-chlorophenyl)acetate in the development of new drugs. For instance, a study published in the Journal of Medicinal Chemistry demonstrated the use of this compound as a key intermediate in the synthesis of potent inhibitors of protein-protein interactions (PPIs). These inhibitors have shown promise in treating various diseases, including cancer and neurodegenerative disorders. The ability to introduce specific functional groups through the bromo and chloro substituents allows for fine-tuning of the pharmacological properties of the final drug candidates.

In addition to its role in PPI inhibitors, Methyl 2-(2-bromo-3-chlorophenyl)acetate has also been utilized in the synthesis of small molecules targeting G protein-coupled receptors (GPCRs). GPCRs are a large family of membrane proteins involved in numerous physiological processes and are important targets for drug discovery. A recent study published in the European Journal of Medicinal Chemistry reported the successful synthesis of several GPCR ligands using this intermediate. The resulting compounds exhibited high binding affinities and selectivities, making them potential leads for further drug development.

The versatility of Methyl 2-(2-bromo-3-chlorophenyl)acetate extends beyond its use as an intermediate in drug synthesis. It has also found applications in other areas of chemical research, such as materials science and organic synthesis. For example, researchers at the University of California, Berkeley, utilized this compound as a precursor for the preparation of novel polymers with unique optical and electronic properties. The ability to introduce functional groups through the bromo and chloro substituents allowed for precise control over the polymer structure and properties.

From a synthetic perspective, the preparation of Methyl 2-(2-bromo-3-chlorophenyl)acetate involves several well-established chemical reactions. One common approach is to start with 2-bromo-3-chlorobenzaldehyde, which is then converted to the corresponding carboxylic acid through oxidation. The carboxylic acid is subsequently esterified with methanol to yield the final product. This synthetic route is highly efficient and scalable, making it suitable for both laboratory-scale synthesis and industrial production.

In conclusion, Methyl 2-(2-bromo-3-chlorophenyl)acetate (CAS No. 1021089-12-2) is a highly versatile intermediate with significant applications in pharmaceutical and chemical research. Its unique chemical structure and reactivity make it an invaluable tool for the development of novel therapeutic agents and advanced materials. As ongoing research continues to uncover new uses for this compound, its importance in modern chemistry is likely to grow even further.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)